Respiratory syncytial virus in cirrhosis: Time to separate data from dogma?

doi:10.4254/wjh.v18.i5.118665

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 5

This Article

(0) (0) (0) (0) (17)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Hepatol. May 27, 2026; 18(5): 118665
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.118665

Open in New Tab Full Size Figure Download Figure

Figure 1 Respiratory syncytial virus hospitalization rates in chronic conditions and vaccination considerations for cirrhotic patients. A: Comparative bar chart showing a low respiratory syncytial virus (RSV)-related hospitalization rate in cirrhosis (0.3%, according to Walia et al[1]) compared with higher rates in chronic kidney disease, heart failure, and chronic obstructive pulmonary disease, based on real-world Australian hospital data over 8 years; B: Case-by-case considerations for RSV vaccination decisions, prioritizing age > 60 years and cardiopulmonary comorbidities, challenging uniform high-risk classification. COPD: Chronic obstructive pulmonary; CKD: Chronic kidney disease; RSV: Respiratory syncytial virus; CHF: Congestive heart failure; DM: Diabetes mellitus.

Citation: Quarleri J, Delpino MV. Respiratory syncytial virus in cirrhosis: Time to separate data from dogma? World J Hepatol 2026; 18(5): 118665
URL: https://www.wjgnet.com/1948-5182/full/v18/i5/118665.htm
DOI: https://dx.doi.org/10.4254/wjh.v18.i5.118665

Quarleri J, Delpino MV. Respiratory syncytial virus in cirrhosis: Time to separate data from dogma? World J Hepatol 2026; 18(5): 118665 [DOI: 10.4254/wjh.v18.i5.118665]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.